D. Čopíková-Cudráková

发表

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Alzheimer’s Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis

V. Durmanova, K. Gmitterová, D. Čierný, 2022, Life.

Adrenoleukodystrophy--a new mutation identified.

P. Traubner, D. Čopíková-Cudráková, R. Petrovic, 2007, Bratislavske lekarske listy.

Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients

V. Durmanova, K. Gmitterová, D. Čierný, 2017, Folia Microbiologica.

TNFRSF1A polymorphisms and their role in multiple sclerosis susceptibility and severity in the Slovak population

V. Durmanova, K. Gmitterová, D. Čierný, 2018, International journal of immunogenetics.

VLA 4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks ( multiple sclerosis / VLA-4 / integrin / single-nucleotide polymorphism / association study )

V. Durmanova, P. Turčáni, M. Bucova, 2015 .

Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis.

P. Turčáni, M. Novák, D. Čopíková-Cudráková, 2020, Neuro endocrinology letters.

The +190 G/A (rs1799864) polymorphism in the C–C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals

V. Durmanova, K. Gmitterová, E. Klímová, 2015, Journal of the Neurological Sciences.

Neuroendocrinology Letters-Neuro Endocrinol Lett

P. Turčáni, D. Čopíková-Cudráková, J. Hanes, 2020 .